87 related articles for article (PubMed ID: 19776395)
1. Risk of confusion in dosing Tamiflu oral suspension in children.
Parker RM; Wolf MS; Jacobson KL; Wood AJ
N Engl J Med; 2009 Nov; 361(19):1912-3. PubMed ID: 19776395
[No Abstract] [Full Text] [Related]
2. CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.
Budnitz DS; Lewis LL; Shehab N; Birnkrant D
N Engl J Med; 2009 Nov; 361(19):1913-4. PubMed ID: 19797275
[No Abstract] [Full Text] [Related]
3. A caution about giving Tamiflu to children.
Child Health Alert; 2009 Nov; 27():4-5. PubMed ID: 20050174
[No Abstract] [Full Text] [Related]
4. Antiviral therapy and prophylaxis for influenza in children.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
[TBL] [Abstract][Full Text] [Related]
5. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
Rosenborg S
Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
[No Abstract] [Full Text] [Related]
6. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
Greener M
Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
[No Abstract] [Full Text] [Related]
7. Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
Brewster M; Smith JR; Dutkowski R; Robson R
Vaccine; 2006 Nov; 24(44-46):6660-3. PubMed ID: 16797800
[TBL] [Abstract][Full Text] [Related]
8. Oseltamivir dosing in children undergoing hemodialysis.
Schreuder MF; van der Flier M; Knops NB; Koster-Kamphuis L; Brüggemann RJ
Clin Infect Dis; 2010 May; 50(10):1427-8. PubMed ID: 20397934
[No Abstract] [Full Text] [Related]
9. Milliliter-only instructions could reduce parents' dosing errors.
Wallis L
Am J Nurs; 2014 Oct; 114(10):16. PubMed ID: 25251114
[No Abstract] [Full Text] [Related]
10. Oseltamivir oral suspension and capsules are bioequivalent for the active metabolite in healthy adult volunteers.
Lennon S; Barrett J; Kirkpatrick C; Rayner C
Int J Clin Pharmacol Ther; 2009 Aug; 47(8):539-48. PubMed ID: 19640363
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection.
Tanabe T; Hara K; Nakajima M; Shimakawa S; Tamai H
Brain Dev; 2010 Jun; 32(6):440-4. PubMed ID: 19200672
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir: cutaneous and neurological adverse effects in children.
Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
[TBL] [Abstract][Full Text] [Related]
14. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
[TBL] [Abstract][Full Text] [Related]
15. [Oseltamivir suspensions].
Boatemaa LP; Plaizier-Vercammen J
J Pharm Belg; 2010 Dec; (4):100-4. PubMed ID: 21294315
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
[No Abstract] [Full Text] [Related]
17. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
Kubo T; Nishimura H
Phytomedicine; 2007 Feb; 14(2-3):96-101. PubMed ID: 17141491
[TBL] [Abstract][Full Text] [Related]
18. Minimising medication errors in children.
Wong IC; Wong LY; Cranswick NE
Arch Dis Child; 2009 Feb; 94(2):161-4. PubMed ID: 18829622
[TBL] [Abstract][Full Text] [Related]
19. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Robson R; Buttimore A; Lynn K; Brewster M; Ward P
Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
